Iron Mountain Interest Paid increased by 202.3% to $341.79M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 27.9%, from $267.21M to $341.79M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 17.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $32.13M | $177.67M | $32.76M | $179.08M | $48.55M | $183.22M | $71.82M | $204.90M | $65.24M | $200.13M | $42.17M | $274.80M | $108.03M | $261.48M | $126.39M | $267.21M | $119.18M | $325.13M | $113.07M | $341.79M |
| QoQ Change | — | +453.0% | -81.6% | +446.7% | -72.9% | +277.3% | -60.8% | +185.3% | -68.2% | +206.7% | -78.9% | +551.6% | -60.7% | +142.0% | -51.7% | +111.4% | -55.4% | +172.8% | -65.2% | +202.3% |
| YoY Change | — | — | — | — | +51.1% | +3.1% | +119.3% | +14.4% | +34.4% | +9.2% | -41.3% | +34.1% | +65.6% | +30.7% | +199.7% | -2.8% | +10.3% | +24.3% | -10.5% | +27.9% |